RENDERING 3D
/ WHAT YOU WILL RECEIVE
Real photographs of your peptides — boxed, lot-labeled, and shipped in plain unmarked packaging from our partner research lab.
More batch photos and lab footage coming soon.
PEPTIDE SEQUENCE · STRUCTURE NOTE
191 amino acid recombinant Somatropin (rhGH)
Four-helix bundle structural motif; identical primary sequence to pituitary-derived human growth hormone.
⏱ HALF-LIFE · PHARMACOKINETIC PROFILE
Human Growth Hormone (somatropin)
~2–3 hours (subcut)
Short circulating half-life · IGF-1 downstream signaling persists ~24 hours.
EU Warehouse · RESEARCH GRADE
HGH · EU Bulk Kit
10 vials × 36 IU · Lyophilized Vial
⚠ Average ETA 5–7 days · €28–€35 shipping
Recombinant Human Growth Hormone (Somatropin) · 10× 36 IU lyophilized vials (360 IU total). EU-stocked.
UNIT PRICE
€287
EU stock · ships from EU
≈ $0.86 per IU · 360 IU total
Reconstitution required
This compound requires bacteriostatic water for reconstitution. Don't forget to add a 10mL vial of BAC water to your order — available in Lab Supplies.
HOW LONG WILL IT LAST YOU?
Enter your research protocol and vial quantity — see exactly how many weeks your order covers.
Each 36 IU vial lasts
18 days
One kit (10 × 36 IU) lasts
26 weeks
Your 1 × kit (10 vials) order lasts
26weeks
≈ 180 days · 18 doses per vial
FOR RESEARCH USE ONLY
Not for human consumption. Intended for laboratory and in-vitro research applications./ RESEARCH INFORMATION · STANDARDIZED PROFILE
Full breakdown.
Every compound on Helixora ships with a consistent six-section research profile so you can compare and reference quickly.
Overview & Classification
Recombinant human Growth Hormone (Somatropin) — 191-aa pituitary peptide produced via recombinant DNA technology.
Type
Recombinant peptide hormone (191 aa)
Derivation
Recombinant E. coli expression — bioidentical to endogenous pituitary somatropin.
Structural
Single-chain 191-aa polypeptide with 2 disulfide bridges (Cys53-Cys165, Cys182-Cys189). Four-helix bundle tertiary structure.
Mechanism of Action
- ·Binds GH receptors (GHR) → JAK2/STAT5 signaling cascade
- ·Hepatic IGF-1 production → mediates most anabolic effects
- ·Direct lipolysis at adipocytes
- ·Cell proliferation, glucose homeostasis, electrolyte balance
Research Highlights
- ·Body composition: increased lean mass + decreased fat mass
- ·Improved sleep architecture (slow-wave)
- ·Skin / connective tissue improvements
- ·Bone density support in deficient research populations
Research Usage Parameters
- ·Research dose: 2–4 IU subcutaneous daily (0.6–1.4mg)
- ·Pre-bed or split AM/PM dosing common
- ·Cycle: 12–24+ weeks
Pharmacological Profile
Half-life
~3.5 hours circulating
Absorption
Subcutaneous, IM
Distribution
Liver primary; concentrates in tissues with GHR expression
Safety Profile
- ·Common: water retention, joint stiffness, paresthesias
- ·Glucose intolerance at higher doses
- ·Carpal tunnel signal — monitor in extended research
- ·IGF-1 elevation — periodic blood-work in research protocols
/ RESEARCH DOSSIER